Arginine 16 Glycine β2-Adrenoceptor Polymorphism and Cardiovascular Structure and Function in Patients with Heart Failure

Journal of the American Society of Echocardiography

Volumn 20, Issue 3, 2007, Pages 290-297

  Wolk, Robert ^a   Snyder, Eric M ^a   Somers, Virend K ^a   Turner, Stephen T ^a   Olson, Lyle J ^a   Johnson, Bruce D ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ATRIAL NATRIURETIC FACTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; GLYCINE; NORADRENALIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CARDIOVASCULAR FUNCTION; CHRONOTROPISM; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLE; ECHOCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; GENETIC POLYMORPHISM; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RECEPTOR INTRINSIC ACTIVITY;

APOLIPOPROTEINS E; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GLYCINE; HEART FAILURE, CONGESTIVE; HETEROZYGOTE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MINNESOTA; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2; RISK ASSESSMENT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; VARIATION (GENETICS); VENTRICULAR DYSFUNCTION, LEFT;

EID: 33847288768     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2006.08.011     Document Type: Article

References (53)

1. Barnes M.E., Miyasaka Y., Seward J.B., Gersh B.J., Rosales A.G., Bailey K.R., et al. Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation. Mayo Clin Proc 79 (2004) 1008-1014
2. Benedict C.R., Shelton B., Johnstone D.E., Francis G., Greenberg B., Konstam M., et al. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction: SOLVD investigators. Circulation 94 (1996) 690-697
3. Berger R., Strecker K., Huelsmann M., Moser P., Frey B., Bojic A., et al. Prognostic power of neurohumoral parameters in chronic heart failure depends on clinical stage and observation period. J Heart Lung Transplant 22 (2003) 1037-1045
4. Bray M.S., Krushkal J., Li L., Ferrell R., Kardia S., Sing C.F., et al. Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 101 (2000) 2877-2882
5. Brodde O.E. Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43 (1991) 203-242
6. Brodde O.E., Bruck H., Leineweber K., and Seyfarth T. Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Basic Res Cardiol 96 (2001) 528-538
7. Brodde O.E., and Michel M.C. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 51 (1999) 651-690
8. Burnett Jr. J.C., Kao P.C., Hu D.C., Heser D.W., Heublein D., Granger J.P., et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 231 (1986) 1145-1147
9. Chong L.K., Chowdry J., Ghahramani P., and Peachell P.T. Influence of genetic polymorphisms in the beta2-adrenoceptor on desensitization in human lung mast cells. Pharmacogenetics 10 (2000) 153-162
10. Cockcroft J.R., Gazis A.G., Cross D.J., Wheatley A., Dewar J., Hall I.P., et al. Beta(2)-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 36 (2000) 371-375
11. Cohn J.N., Levine T.B., Olivari M.T., Garberg V., Lura D., Francis G.S., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311 (1984) 819-823
12. del Monte F., Kaumann A.J., Poole-Wilson P.A., Wynne D.G., Pepper J., and Harding S.E. Coexistence of functioning beta 1- and beta 2-adrenoceptors in single myocytes from human ventricle. Circulation 88 (1993) 854-863
13. Dishy V., Sofowora G.G., Xie H.G., Kim R.B., Byrne D.W., Stein C.M., et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 345 (2001) 1030-1035
14. Eisenach J.H., Barnes S.A., Pike T.L., Sokolnicki L.A., Masuki S., Dietz N.M., et al. The Arg16/Gly {beta}2-adrenergic receptor polymorphism alters the cardiac output response to isometric exercise. J Appl Physiol 99 (2005) 1776-1781
15. Eisenach J.H., McGuire A.M., Schwingler R.M., Turner S.T., and Joyner M.J. The Arg16/Gly beta2-adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise. Physiol Genomics 16 (2004) 323-328
16. Elhendy A., Mahoney D.W., Khandheria B.K., Burger K., and Pellikka P.A. Prognostic significance of impairment of heart rate response to exercise: impact of left ventricular function and myocardial ischemia. J Am Coll Cardiol 42 (2003) 823-830
17. Engelhardt S., Hein L., Wiesmann F., and Lohse M.J. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A 96 (1999) 7059-7064
18. Flesch M., Ettelbruck S., Rosenkranz S., Maack C., Cremers B., Schluter K.D., et al. Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytes. Cardiovasc Res 49 (2001) 371-380
19. Fowler M.B., Laser J.A., Hopkins G.L., Minobe W., and Bristow M.R. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation 74 (1986) 1290-1302
20. Garovic V.D., Joyner M.J., Dietz N.M., Boerwinkle E., and Turner S.T. Beta(2)-adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans. J Physiol 546 (2003) 583-589
21. Gilbert E.M., Abraham W.T., Olsen S., Hattler B., White M., Mealy P., et al. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation 94 (1996) 2817-2825
22. Gottlieb S.S., Kukin M.L., Ahern D., and Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 13 (1989) 1534-1539
23. Heckbert S.R., Hindorff L.A., Edwards K.L., Psaty B.M., Lumley T., Siscovick D.S., et al. Beta2-adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly. Circulation 107 (2003) 2021-2024
24. Hurrell D.G., Oh J.K., Mahoney D.W., Miller Jr. F.A., and Seward J.B. Short deceleration time of mitral inflow E velocity: prognostic implication with atrial fibrillation versus sinus rhythm. J Am Soc Echocardiogr 11 (1998) 450-457
25. Iyengar S., and Abraham W.T. Pharmacogenomics and heart failure: tailor-made therapy?. Congest Heart Fail 10 (2004) 273-288
26. Kaumann A., Bartel S., Molenaar P., Sanders L., Burrell K., Vetter D., et al. Activation of beta2-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure. Circulation 99 (1999) 65-72
27. Kurz T., Richardt D., Gorge B., Hartmann F., Tolg R., Katus H.A., et al. Differential effects of carvedilol on norepinephrine release in normoxic and ischemic heart. J Cardiovasc Pharmacol 36 (2000) 96-100
28. Lanfear D.E., Jones P.G., Marsh S., Cresci S., McLeod H.L., and Spertus J.A. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. JAMA 294 (2005) 1526-1533
29. Lauer M.S., Okin P.M., Larson M.G., Evans J.C., and Levy D. Impaired heart rate response to graded exercise: prognostic implications of chronotropic incompetence in the Framingham heart study. Circulation 93 (1996) 1520-1526
30. Lefkowitz R.J., Rockman H.A., and Koch W.J. Catecholamines, cardiac beta-adrenergic receptors, and heart failure. Circulation 101 (2000) 1634-1637
31. Liggett S.B., Tepe N.M., Lorenz J.N., Canning A.M., Jantz T.D., Mitarai S., et al. Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 101 (2000) 1707-1714
32. Liggett S.B., Wagoner L.E., Craft L.L., Hornung R.W., Hoit B.D., McIntosh T.C., et al. The Ile 164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 102 (1998) 1534-1539
33. Lohse M.J., Engelhardt S., and Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure?. Circ Res 93 (2003) 896-906
34. McGraw D.W., Forbes S.L., Mak J.C., Carrigan P.E., Leikauf G.D., and Liggett S.B. Transgenic overexpression of beta(2)-adrenergic receptors in airway epithelial cells decreases bronchoconstriction. Am J Physiol Lung Cell Mol Physiol 279 (2000) L379-L389
35. McGraw D.W., Fukuda N., James P.F., Forbes S.L., Woo A.L., Lingrel J.B., et al. Targeted transgenic expression of beta(2)-adrenergic receptors to type II cells increases alveolar fluid clearance. Am J Physiol Lung Cell Mol Physiol 281 (2001) L895-L903
36. Milano C.A., Allen L.F., Rockman H.A., Dolber P.C., McMinn T.R., Chien K.R., et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science 264 (1994) 582-586
37. Molenaar P., Bartel S., Cochrane A., Vetter D., Jalali H., Pohlner P., et al. Both beta(2)- and beta(1)-adrenergic receptors mediate hastened relaxation and phosphorylation of phospholamban and troponin I in ventricular myocardium of Fallot infants, consistent with selective coupling of beta(2)-adrenergic receptors to G(s)-protein. Circulation 102 (2000) 1814-1821
38. Moller J.E., Hillis G.S., Oh J.K., Seward J.B., Reeder G.S., Wright R.S., et al. Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation 107 (2003) 2207-2212
39. Myers J., and Gullestad L. The role of exercise testing and gas-exchange measurement in the prognostic assessment of patients with heart failure. Curr Opin Cardiol 13 (1998) 145-155
40. Oh J.K., Appleton C.P., Hatle L.K., Nishimura R.A., Seward J.B., and Tajik A.J. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 10 (1997) 246-270
41. Proctor D.N., and Beck K.C. Delay time adjustments to minimize errors in breath-by-breath measurement of Vo2 during exercise. J Appl Physiol 81 (1996) 2495-2499
42. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
43. Snyder E.M., Beck K.C., Dietz N.M., Eisenach J.H., Joyner M.J., Turner S.T., et al. Arg16Gly polymorphism of the {beta}2-adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans. J Physiol 571 (2006) 121-130
44. Snyder E.M., Beck K.C., Dietz N.M., Joyner M.J., Turner S.T., and Johnson B.D. Influence of {beta}2-adrenergic receptor genotype on airway function during exercise in healthy adults. Chest 129 (2006) 762-770
45. Snyder E.M., Hulsebus M.L., Turner S.T., Joyner M.J., and Johnson B.D. Genotype related differences in beta2 adrenergic receptor density and cardiac function. Med Sci Sports Exerc 38 (2006) 882-886
46. Snyder E.M., and Johnson B.D. Beta2-adrenergic receptor genotype and survival after acute coronary syndrome. JAMA 295 (2006) 756-758
47. Swedberg K., Eneroth P., Kjekshus J., and Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality: CONSENSUS trial study group. Circulation 82 (1990) 1730-1736
48. Tsang T.S., Barnes M.E., Gersh B.J., Bailey K.R., and Seward J.B. Risks for atrial fibrillation and congestive heart failure in patients >/=65 years of age with abnormal left ventricular diastolic relaxation. Am J Cardiol 93 (2004) 54-58
49. Tsang T.S., Barnes M.E., Gersh B.J., Takemoto Y., Rosales A.G., Bailey K.R., et al. Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J Am Coll Cardiol 42 (2003) 1199-1205
50. Wagoner L.E., Craft L.L., Singh B., Suresh D.P., Zengel P.W., McGuire N., et al. Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res 86 (2000) 834-840
51. White M., Yanowitz F., Gilbert E.M., Larrabee P., O'Connell J.B., Anderson J.L., et al. Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol 76 (1995) 1271-1276
52. Xiao R.-P., Tomhave E.D., Wang D.-J., Ji X., Boluyt M.O., Cheng H., et al. Age-associated reductions in cardiac beta 1- and beta 2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest 101 (1998) 1273-1282
53. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203